http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101336143-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 |
filingDate | 2011-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2013-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101336143-B1 |
titleOfInvention | Clopidogrel's Cocrystal |
abstract | The present invention relates to a co-crystal of clopidogrel consisting of Clopidogrel bisulfate and nicotinamide or isonicotinamide, a pharmaceutical composition comprising the above-mentioned co-crystal of clopidogrel as an active ingredient, and a method for preparing the co-crystal of clopidogrel as described above. It is about. The cocrystal of clopidogrel of the present invention exhibits a completely different physical and chemical aspect compared to conventional clopidogrel hydrogen sulfate. In particular, the co-crystal of clopidogrel of the present invention is excellent in stability to heat and light or water, and excellent in solubility in water, and thus is useful as an active ingredient of a pharmaceutical composition. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115650993-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106543127-A |
priorityDate | 2011-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.